LATE-BREAKING ABSTRACT: An electronic nose distinguishes the exhaled breath of patients with pleural malignant mesothelioma from subjects with professional asbestos exposure Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009
Exhaled breath analysis allows exclusive screening for malignant pleural mesothelioma. Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Exhaled breath to screen for malignant pleural mesothelioma: a validation study Source: Eur Respir J, 50 (6) 1700919; 10.1183/13993003.00919-2017 Year: 2017
Lung function in patients with benign asbestos related pleural disease Source: Eur Respir J 2003; 22: Suppl. 45, 185s Year: 2003
Pleural neoplasms – linkage with professional asbestos exposure Source: Eur Respir J 2006; 28: Suppl. 50, 702s Year: 2006
A breath test for malignant mesothelioma using an electronic nose Source: Eur Respir J 2012; 40: 448-454 Year: 2012
Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients. Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021
Proportion of patients with malignant pleural mesothelioma whose asbestos body numbers in the lung are equal to general population Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Features of bronchial carcinoma cases with environmental asbestos exposure Source: Eur Respir J 2004; 24: Suppl. 48, 301s Year: 2004
Features of bronchial carcinoma cases with environmental asbestos exposure Source: Eur Respir J 2001; 18: Suppl. 33, 534s Year: 2001
Clinical features of lung cancer sufferers radiologically determined to have had previous exposure to asbestos Source: Eur Respir J 2006; 28: Suppl. 50, 75s Year: 2006
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
Exploration of breath analysis to monitor therapeutic response in mesothelioma patients Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019
Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study Source: Eur Respir J 2005; 26: 875-880 Year: 2005
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air? Source: Eur Respir Rev, 27 (147) 170098; 10.1183/16000617.0098-2017 Year: 2018
Occupational and enviromental determinants of exposure to asbestos in malignant mesothelioma cases Source: Annual Congress 2011 - Mineral dusts Year: 2011
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016
Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients Source: Eur Respir J, 58 (2) 2003024; 10.1183/13993003.03024-2020 Year: 2021
Pleural plaques in dentists from occupational asbestos exposure Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease Year: 2009
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010